Search

everythinglearnresearchcommunity

for

Search:↓

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Age and other health issues affect erectile dysfunction more than finasteride or alpha-blockers.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.